flow trial semaglutide kidney outcomes Study: slowed progression of CKD, cut cardiovascular events, mortality risk FLOW trial for semaglutide kidney
Description
Hunger can still occur even at higher doses due to factors like stress, sleep, diet quality, or individual metabolic response
Glutathione can be administered as a shot or a push at the end of IV vitamin therapy

Plain water is inadequate for ESD: insufficient conductivity higher diathermy settings required Isotonic saline (0.9% NaCl): electrolyte-rich conductive medium facilitates cutting, coagulation and vessel precoagulation ESGE 2023 guidelines explicitly endorse saline over water in immersion-assisted ESD SITE-PCM: especially powerful combination the pocket stabilises the dissection plane, SITE optimises optics, buoyancy and diathermy performance Asclepius tube: continuous drainage of excess saline without repeated through-the-scope suctioning Western cohort data (181 lesions, Royal Free): R0 92.3%, curative resection 90.6%, 93.4% under conscious sedation, 0.5% surgery rate Conclusion: SITE is not a competitor to conventional ESD it is a flexible adjunct, most valuable in fibrotic lesions, anatomically challenging segments, and for broadening access to ESD without general anaesthesia

But with less than two weeks before its launch, questions remain over how it will operate
Artificial sweeteners have long been studied for their safety and impact on health
